Investor science conference call ACC 2015
16 March 2015
Presentation of data by the PEGASUS-TIMI 54 trial’s primary investigator Dr. Marc Sabatine to investors and analysts which was followed by a clinical and business status update.
Investor Relations presentation - March 2015
5 March 2015
Background presentation for latest financial information, product performance and progress on development pipeline of potential new medicines. Updated March 2015.
Fourth quarter and full year results 2014
5 February 2015
AstraZeneca announced fourth quarter and full year results for 2014 on Thursday 5th February 2015. Presentations made by Pascal Soriot, Chief Executive Officer; Marc Dunoyer, Chief Financial Officer; Briggs Morrison, EVP Global Medicines Development and Luke Miels EVP GPPS.
- Download presentation (PDF 1911kb)
- Press release & development pipeline (PDF 534kb)
- Clinical trials appendix (PDF 657kb)
33rd J.P. Morgan Healthcare Conference, San Francisco
14 January 2015